China Diabetes Market Report 2024-2032: China Currently has the Highest Number of Diabetics in the World
22 juil. 2024 04h22 HE
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "China Diabetes Market Report: 2024-2032" report has been added to ResearchAndMarkets.com's offering.The China diabetes market size reached US$ 4.7...
Diabetes Pen Market Insights, Competitive Landscape and Market Forecast 2024-2030
11 juil. 2024 11h17 HE
|
Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "Diabetes Pen - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The...
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
24 juin 2024 06h30 HE
|
Embecta Corp.
embecta-sponsored abstracts presented at ADA's 84th Scientific Sessions highlight unmet need for patch pumps with 300u insulin reservoir
Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity Market Analysis 2024 - The Use of GLP-1R Agonists is Expected to Quadruple in the Next 10 Years, at a CAGR of 14.9%
04 juin 2024 04h17 HE
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Glucagon-Like Peptide 1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven-Market Drug Forecast and Market Analysis" report has been...
Global Insulin Delivery Systems Strategic Research Report 2024-2030 - Constantly Expanding R&D Activities and New Pioneering Treatments Influence Growth
21 mai 2024 05h44 HE
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Insulin Delivery Systems...
At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes
20 mai 2024 07h00 HE
|
Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor” or “the Company”) AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN DEMONSTRATES SUPERIORITY IN PHASE I CLINICAL TRIAL IN OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2...
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
09 mai 2024 07h00 HE
|
Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor” or the “Company”) ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund...
Global Prediabetes Treatment Market Analysis & Forecast Report 2024-2034
23 avr. 2024 04h01 HE
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Global Prediabetes Treatment Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Comprehensive Market Analysis Reveals Significant Insights into the Insulin Pumps and Continuous Glucose Monitors Market Through 2033
03 avr. 2024 12h04 HE
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pumps and Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added...
Dyadic Reports 2023 Full Year Results and Recent Company Progress
28 mars 2024 16h00 HE
|
Dyadic International, Inc.
Closed a $6.0 million convertible note in a private placement, with a conversion price of $1.79 and no warrantsReported positive topline data from First-In-Human Phase 1 trial demonstrated clinical...